Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul L. Alpern sold 3,609 shares of the business’s stock in a transaction on Friday, April 4th. The shares were sold at an average price of $6.03, for a total transaction of $21,762.27. Following the transaction, the vice president now owns 83,717 shares of the company’s stock, valued at $504,813.51. This represents a 4.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Arteris Stock Performance
AIP traded down $0.61 on Friday, reaching $5.99. The stock had a trading volume of 225,185 shares, compared to its average volume of 195,798. The business’s 50-day moving average price is $8.70 and its two-hundred day moving average price is $8.78. The company has a market cap of $245.28 million, a P/E ratio of -6.88 and a beta of 1.21. Arteris, Inc. has a 12-month low of $5.76 and a 12-month high of $12.64. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30.
Arteris (NASDAQ:AIP – Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The business had revenue of $15.49 million during the quarter, compared to analysts’ expectations of $15.34 million. Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. Sell-side analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on AIP shares. Northland Securities lifted their price objective on Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Wednesday, February 19th. Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Tuesday, February 18th.
Get Our Latest Report on Arteris
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
- Five stocks we like better than Arteris
- Health Care Stocks Explained: Why You Might Want to Invest
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Financial Services Stocks Investing
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Dividend Payout Ratio Calculator
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.